Two heavyweight medical research facilities were established in the Hetao Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone on Thursday — the Greater Bay Area (GBA) International Clinical Trials Center in the Shenzhen park and the GBA International Clinical Trial Institute in the Hong Kong park. Clinical trials are a critical step in translating basic research on drug and medical device innovation into market authorization and clinical application. The two establishments will collaborate to advance clinical trial development and promote cooperation between the clinical trial networks of Hong Kong and the rest of the GBA